m6A modifications play a critical role in regulating angiogenesis in NSCLC, where interactions between cancer-associated fibroblasts (CAFs) and m6A modifications are central in shaping the expression and stability of angiogenic factors such as VEGFA, crucial for tumor vasculature formation. The gene discussed is VEGFA; the disease is neoplasm.